Roche Holding AG
RHO5
Company Profile
Business description
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
Contact
Grenzacherstrasse 124
Basel4070
CHET: +41 616881111
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2024
Employees
103,605
Roche Holding AG News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,567.00 | 12.10 | -0.14% |
CAC 40 | 7,213.32 | 14.87 | 0.21% |
DAX 40 | 19,146.17 | 141.39 | 0.74% |
Dow JONES (US) | 43,792.38 | 383.91 | 0.88% |
FTSE 100 | 8,149.27 | 64.20 | 0.79% |
HKSE | 19,601.11 | 103.90 | -0.53% |
NASDAQ | 18,930.80 | 35.34 | -0.19% |
Nikkei 225 | 38,026.17 | 326.17 | -0.85% |
NZX 50 Index | 12,765.24 | 28.18 | 0.22% |
S&P 500 | 5,936.57 | 19.46 | 0.33% |
S&P/ASX 200 | 8,323.00 | 3.30 | -0.04% |
SSE Composite Index | 3,370.40 | 2.41 | 0.07% |